Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

LRMR

Larimar Therapeutics, Inc.

CIK 0001374690 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$4.18
↑ 0.02 (0.48%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Options; Risks: Fundamentals

Key stats

Market Cap
$434.23M
P/E Ratio
-2.52
EPS
Not covered
Dividend Yield
Not covered
52W Position
40%
Beta
1.87

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
3.41
P/S
Not covered
EV/Revenue
Not covered
ROE
-135.5%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 40%
$2.71$6.42

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$165.67M
Total Assets
$145.84M
Free Cash Flow
-$113.29M

Recent news